Israel
· Delayed Price · Currency is ILS · Price in ILARazor Labs Statistics
Total Valuation
Razor Labs has a market cap or net worth of ILS 170.32 million. The enterprise value is 137.69 million.
| Market Cap | 170.32M |
| Enterprise Value | 137.69M |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Razor Labs has 39.26 million shares outstanding. The number of shares has decreased by -1.57% in one year.
| Shares Outstanding | 39.26M |
| Shares Change (YoY) | -1.57% |
| Shares Change (QoQ) | +1.65% |
| Owned by Insiders (%) | 78.26% |
| Owned by Institutions (%) | 2.33% |
| Float | 8.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.40 |
| PB Ratio | 9.10 |
| P/FCF Ratio | 13.11 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.33 |
| EV / Sales | 16.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 10.60 |
Financial Position
The company has a current ratio of 2.74, with a Debt / Equity ratio of 84.87.
| Current Ratio | 2.74 |
| Quick Ratio | 2.72 |
| Debt / Equity | 84.87 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.22 |
| Interest Coverage | -14.19 |
Financial Efficiency
Return on equity (ROE) is -62.31% and return on invested capital (ROIC) is -24.61%.
| Return on Equity (ROE) | -62.31% |
| Return on Assets (ROA) | -15.79% |
| Return on Capital (ROIC) | -24.61% |
| Revenue Per Employee | 305,074 |
| Profits Per Employee | -611,926 |
| Employee Count | 27 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +834.42% in the last 52 weeks. The beta is 2.65, so Razor Labs's price volatility has been higher than the market average.
| Beta (5Y) | 2.65 |
| 52-Week Price Change | +834.42% |
| 50-Day Moving Average | 439.22 |
| 200-Day Moving Average | 408.20 |
| Relative Strength Index (RSI) | 46.00 |
| Average Volume (20 Days) | 141,598 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Razor Labs had revenue of ILS 8.24 million and -16.52 million in losses. Loss per share was -0.43.
| Revenue | 8.24M |
| Gross Profit | 2.15M |
| Operating Income | -17.32M |
| Pretax Income | -16.51M |
| Net Income | -16.52M |
| EBITDA | -16.71M |
| EBIT | -17.32M |
| Loss Per Share | -0.43 |
Balance Sheet
The company has 48.47 million in cash and 15.82 million in debt, giving a net cash position of 32.65 million or 0.83 per share.
| Cash & Cash Equivalents | 48.47M |
| Total Debt | 15.82M |
| Net Cash | 32.65M |
| Net Cash Per Share | 0.83 |
| Equity (Book Value) | 18.64M |
| Book Value Per Share | 0.48 |
| Working Capital | 33.49M |
Cash Flow
In the last 12 months, operating cash flow was 13.05 million and capital expenditures -65,000, giving a free cash flow of 12.99 million.
| Operating Cash Flow | 13.05M |
| Capital Expenditures | -65,000 |
| Free Cash Flow | 12.99M |
| FCF Per Share | 0.33 |
Margins
Gross margin is 26.15%, with operating and profit margins of -210.32% and -200.58%.
| Gross Margin | 26.15% |
| Operating Margin | -210.32% |
| Pretax Margin | -200.39% |
| Profit Margin | -200.58% |
| EBITDA Margin | -202.84% |
| EBIT Margin | -210.32% |
| FCF Margin | 157.69% |
Dividends & Yields
Razor Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.57% |
| Shareholder Yield | 1.57% |
| Earnings Yield | -9.91% |
| FCF Yield | 7.63% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |